Peptide Atlas · Peptide

Setmelanotide

Setmelanotide is a melanocortin-4 receptor agonist, first approved in the United States for chronic weight management in patients aged 6 and older with obesity caused by POMC, PCSK1 or leptin receptor deficiency.

established

provisional
PubChem 11993702
1 citation
0 discussions
0 followers
BIM-22493
Imcivree
MC4R agonist
RM-493
Setmelanotide acetate

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 1 citation resolves to their original source. · 0 posts naming it, 0 members counted once each.

No personal-experience post names it yet. When a member describes their own experience, PACIFIER reads it as such and it is listed here — labelled as experience, never as advice.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.